Funded Health Care Startups in Netherlands
Disclosed funding in this Netherlands health care set is highly top-heavy: the largest disclosed round is Vitestro’s $70M on 2026-03-10, which sits well ab…
Disclosed funding in this Netherlands health care set is highly top-heavy: the largest disclosed round is Vitestro’s $70M on 2026-03-10, which sits well above the next-largest disclosed amounts (ViCentra at $13M on 2026-01-08 and Microsure at $40M on 2023-10-04, with most other disclosed rounds below that). The other extreme is a set of small, low-single-digit grants, including Plasmacure’s $7M (2025-07-07) down to Speaklee’s $410K (2025-08-12) and the smallest disclosed figure here, $320K (Pal, 2023-09-20).
The rounds cluster around specific periods and geographies. Most recent activity spans 2026-03-10 back to 2020-05-18, but there is a visible late-2025 concentration (multiple entries in August–May 2025, including CardiacBooster’s $11M on 2025-08-07 and Speaklee’s $410K on 2025-08-12). Amsterdam, Noord-Holland appears repeatedly (e.g., Speaklee 2025-08-12, Platos 2025-05-07, Yoni 2023-12-14), while “Series Unknown” is common (9 rows) and “undisclosed” is also present (3 rows), which can complicate stage comparisons from deal sizing alone.
Most recent rounds
45 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Netherlands health care list, and is it an outlier versus the rest?
Vitestro’s $70M on 2026-03-10 is the only disclosed round above $50M in the shown data; the next-largest disclosed figure is Microsure’s $40M on 2023-10-04, and then ViCentra’s $13M on 2026-01-08.
Where do the rounds cluster temporally within the 2020–2026 window shown?
There’s a late-2025 run concentrated in and around August 2025 through May 2025, including Speaklee ($410K, 2025-08-12), CardiacBooster ($11M, 2025-08-07), Hy2Care ($5M, 2025-05-14), and Platos ($1M, 2025-05-07). The earliest disclosed round date in the list is 2020-05-18 (GATT Technologies, $11M), with the most recent being 2026-03-10 (Vitestro, $70M).
Are any cities over-represented among funded companies here?
Amsterdam, Noord-Holland appears multiple times across different stages and sizes, including Speaklee (2025-08-12, $410K), Platos (2025-05-07, $1M), Yoni (2023-12-14, $3M), and FunXtion (2022-09-01, $6M). By contrast, some other cities show up only once in the displayed rows (e.g., Utrecht: Vitestro 2026-03-10 $70M).
How should stage analysis be handled given missing or ambiguous deal sizing fields?
Stage labels are frequently incomplete: “Series Unknown” appears 9 times (e.g., Speaklee 2025-08-12, $410K and Sirius Medical 2025-02-04, $10M), and “undisclosed” appears 3 times (e.g., Vivolta 2023-10-26, amount undisclosed; Binqy 2023-09-26, amount undisclosed; 4MedBox 2023-05-23, amount undisclosed). That makes cross-stage comparisons dependent on disclosed amounts rather than stage name alone.
Which companies sit at the low end of disclosed round sizes, and how extreme is that low tail?
The smallest disclosed amount shown is Pal at $320K on 2023-09-20. Several other sub-$1M disclosed rounds cluster near that floor (e.g., AVIGI Therapeutics $380K on 2025-04-04; ExCulture $380K on 2023-12-05; Layco $330K on 2023-11-21), creating a long low-disclosed tail below mid-single-digit millions.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.